https://www.selleckchem.com/pr....oducts/pkc-theta-inh
As life expectancy of people with Down syndrome (DS) increases, so does the risk of Alzheimer's disease (AD). Identifying symptoms and tracking disease progression is especially challenging whenever levels of function vary before the onset of dementia. Goal Attainment Scaling (GAS), an individualized patient-reported outcome, can aid in monitoring disease progression and treatment effectiveness in adults with DS. Here, with clinical input, a validated dementia symptom menu was revised to facilitate GAS in adults living with
Aimer
Commentaire
Partagez
ethan mark
supprimer les commentaires
Etes-vous sûr que vous voulez supprimer ce commentaire ?
ethan mark
supprimer les commentaires
Etes-vous sûr que vous voulez supprimer ce commentaire ?